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Abstract
Chronic wasting disease (CWD), a transmissible spongiform encephalopathy of cervids, remains prevalent in North American
elk, white-tailed deer and mule deer. A natural case of CWD in reindeer (Rangifer tarandus tarandus) has not been reported
despite potential habitat overlap with CWD-infected deer or elk herds. This study investigates the experimental transmission
of CWD from elk or white-tailed deer to reindeer by the oral route of inoculation. Ante-mortem testing of the three reindeer
exposed to CWD from white-tailed deer identified the accumulation of pathological PrP (PrP
CWD) in the recto-anal mucosa
associated lymphoid tissue (RAMALT) of two reindeer at 13.4 months post-inoculation. Terminal CWD occurred in the two
RAMALT-positive reindeer at 18.5 and 20 months post-inoculation while one other reindeer in the white-tailed deer CWD
inoculum group and none of the 3 reindeer exposed to elk CWD developed disease. Tissue distribution analysis of PrP
CWD in
CWD-affected reindeer revealed widespread deposition in central and peripheral nervous systems, lymphoreticular tissues,
the gastrointestinal tract, neuroendocrine tissues and cardiac muscle. Analysis of prion protein gene (PRNP) sequences in
the 6 reindeer identified polymorphisms at residues 2 (V/M), 129 (G/S), 138 (S/N) and 169 (V/M). These findings demonstrate
that (i) a sub-population of reindeer are susceptible to CWD by oral inoculation implicating the potential for transmission to
other Rangifer species, and (ii) certain reindeer PRNP polymorphisms may be protective against CWD infection.
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Introduction
Chronic wasting disease (CWD) is an invariably fatal neurode-
generative disease of cervids belonging to the transmissible
spongiform encephalopathy (TSE) group of disorders which
include Creutzfeldt-Jakob disease (CJD) in humans, bovine
spongiform encephalopathy (BSE) in cattle and scrapie in sheep
and goats. Common among TSEs is a pathogenesis contingent on
the conversion of a normal host-encoded prion protein (PrP
C)t o
an abnormal disease-associated isoform (PrP
CWD) which accumu-
lates in the nervous system and other tissues, resulting in the
progressive manifestation of clinical disease. CWD is the only TSE
maintained in free-ranging wildlife and the relatively efficient
horizontal transmissibility of CWD between conspecific cervids
presumably relates to the excretion of infectivity in saliva, urine
and feces [1,2] as well as its resiliency in contaminated
environments [3,4]. The transmissibility of CWD from cervids
to domestic livestock, humans and other interacting wildlife species
(e.g. carnivores) remains uncertain although current evidence
suggests a considerable species barrier markedly impedes, if not
prevents such transmission under natural circumstances.
Since the identification of CWD in captive deer in Colorado in
1967 [5], it has been described in captive and wild cervid
populations in several US states, three Canadian provinces and
Korea [6,7,8]. Naturally affected cervid species include mule deer
(Odocoileus hemionus), white-tailed deer (Odocoileus virginianus), Rocky
Mountain elk (Cervus elaphus nelsoni) and moose (Alces alces) [7].
Experimentally, CWD has been orally transmitted to red deer
(Cervus elaphus elaphus) [9], with similar clinical and pathological
findings to CWD in other cervids.
Chronic wasting disease in reindeer (Rangifer tarandus tarandus),
or closely related caribou (e.g. Rangifer tarandus caribou, Rangifer
tarandus granti, Rangifer tarandus groenlandicus) has not yet been
reported despite the potential overlap in natural host ranges with
CWD-susceptible cervids in North America. Determining trans-
missibility of CWD to reindeer and caribou is of particular
importance given the cultural significance of these species to the
aboriginal peoples of northern North America and Eurasia, the
critically reduced populations of many reindeer and caribou
herds, and the potential for some highly migratory herds to
further disseminate CWD. Here we investigate the oral
transmission of CWD from elk (CWD
ELK) or white-tailed deer
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WTD) to reindeer and describe associated genetic, clinical
and pathological findings.
Results
Antemortem Testing
Animals were subjected to recto-anal mucosal lymphoid tissue
(RAMALT) biopsy at various time points after inoculation to
determine if they had been infected with CWD. Two of the 3
reindeer inoculated with CWD
WTD (Reindeer 12 and 47) showed
marked accumulations of PrP
CWD in RAMALT germinal centers
at 13.4 and 16.2 months post-inoculation (mpi)(Figure 1, Table 1).
Testing of the biopsy material from month 16.2 by western blot
and ELISA confirmed the presence of PrP
CWD in the same two
animals with ELISA optical density (OD) values of 1.519 and
1.484 (negative OD cut-off =0.19). The 3
rd reindeer in the
CWD
WTD inoculum group (Reindeer 17) was negative for
PrP
CWD in all RAMALT samples by ELISA, western blot and
IHC, with last sampling conducted at 25 mpi. Similarly, none of
the reindeer inoculated with CWD
ELK (Reindeer 1, 2 and 60)
showed detectable PrP
CWD in RAMALT biopsies at 7.5, 12, 17.5
or 54.8 mpi.
Clinical Signs
Beginning around 17.7 to 18.2 mpi the two RAMALT-positive
reindeer inoculated with CWD
WTD (Reindeer 12 and 47) began to
show subtle weight loss and uneven hair coat. After briefly
displaying ataxia, excessive salivation and grinding of the teeth
both animals developed terminal CWD at 18.5 and 20 mpi. Other
than markedly reduced subcutaneous, abdominal and thoracic
adipose stores, gross lesions were not identified at necropsy. The
third, RAMALT-negative reindeer (Reindeer 17) inoculated with
CWD
WTD remains alive and has shown no clinical signs of CWD
(currently @ 26 mpi). The reindeer receiving the CWD
ELK
inoculum (Reindeer 1, 2 and 60) did not display clinical signs of
CWD at any time during the study and were euthanized at 22.6,
45.3 and 60.9 mpi, respectively.
Histopathology and Immunohistochemistry
Histopathological examination of brain tissues from both
clinically affected reindeer revealed widespread spongiform
pathology characterized by regionally extensive vacuolation of
the grey matter neuropil and rare neuronal perikarya. Lesions
were most prominent in the medulla, particularly the dorsal vagal
nucleus (Figure 1), nucleus of the solitary tract, the reticular
formation, cuneate nuclei and nucleus of the spinal tract of the
trigeminal nerve. Notable spongiform change was also identified
elsewhere in the brainstem, striatum, thalamus, cerebellum and to
a lesser extent in the cerebral cortex.
Localization of PrP
CWD by IHC identified accumulations
throughout the central and peripheral nervous systems, lympho-
reticular tissues and neuroendocrine tissues of the two reindeer
displaying clinical signs (Table 2, Figure 1). The tissue distribution
and intensity of PrP
CWD accretion was generally consistent
between both CWD-positive reindeer. Tissues listed in Table 2
were concurrently tested by a commercially available ELISA kit
and results were found to corroborate IHC findings (data not
shown). Conversely, PrP
CWD-specific immunolabeling was not
detected by IHC or ELISA in any of the tissues collected from the
3 non-clinical reindeer receiving the CWD
ELK inoculum.
Consistent with the distribution of spongiform pathology,
PrP
CWD was distributed throughout the brain with highest
intensity in the medulla and relatively lower deposition in the
cerebral cortex. The most abundant type of PrP
CWD accumulation
in the central nervous system was fine particulate, accompanied by
coarse granular and coalescing deposits in heavily affected regions.
Throughout sections at all levels of spinal cord, particulate and
granular PrP
CWD accumulations were present in the dorsal, lateral
and ventral horns, scattered lightly around white matter and
within perikarya of the dorsal root ganglia. In the eye, PrP
CWD was
most prominent in outer and inner plexiform layers of the retina
with a scant presence in the ganglion cell layer and optic nerve.
In the peripheral nervous system, occasional perineuronal
PrP
CWD was found in trigeminal and celiac ganglia. Scant, coarse
granular PrP
CWD was identified along nerve fibers and in
association with perikarya of the sympathetic trunk, while sciatic
and phrenic nerves did not contain detectable PrP
CWD. Occa-
sional granular PrP
CWD was present within nerve fascicles of the
vagus nerve. Prominent accumulations of PrP
CWD were consis-
tently affiliated with neurons of the submucosal and myenteric
plexuses throughout the gastrointestinal tract and in small ganglia
associated with the submandibular salivary gland and bladder.
All tissues of the lymphoreticular system, regardless of their
proximity to the gastrointestinal tract, displayed particularly
intense PrP
CWD accumulations in association with lymphoid
follicle germinal centers. The percentage of follicles affected in
each lymph node or tonsil was typically between 90 and 100
Figure 1. Tissue distribution of PrP
CWD and histopathology in
clinically affected reindeer orally inoculated with CWD from
white-tailed deer. IHC detection of PrP
CWD using MAb F99/97.6.1
demonstrates: (A) immunolabeling associated with tingible body
macrophages and follicular dendritic cells in a RAMALT biopsy taken
at 13.4 mpi, (C) punctate staining in cardiomyocytes, (D) widespread
particulate deposits in the dorsal vagal nucleus, (E) immunolabeling
within a ganglion adjacent to the submandibular salivary gland, (F)
granular PrP
CWD in submucosal and myenteric plexuses of the ileum
and (G) amongst glomerular lymphocytic infiltrates. (B) Haematoxylin
and eosin stained section of the dorsal vagal nucleus reveals
vacuolation of the neuropil. (H) PET blot of the obex demonstrating
abundant widespread PrP
CWD filling the dorsal vagal nucleus and
surrounding nuclei. Bars, 150 mm (A); 65 mm (B,D,E); 24 mm (C,G); 92 mm
(F); 2.4 mm (H).
doi:10.1371/journal.pone.0039055.g001
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found to be affected by mild lymphocytic infiltrates which stained
positive for PrP
CWD. Similarly, rare lymphoid aggregates within
lung tissue were associated with modest PrP
CWD deposits.
Several neuroendocrine tissues also contained abundant
PrP
CWD deposits. Coarse granular staining within the pancreas
was restricted to the islets of Langerhans and deposits in the
adrenal gland were predominantly confined to the medulla. The
pituitary gland contained heavy PrP
CWD staining in the pars
nervosa and intermedia while rare granular staining was found in
association with parafollicular cells of the thyroid gland. Thorough
examination of several skeletal muscle groups by IHC did not
reveal PrP
CWD, however, sections of the ventricular myocardium
were found to contain scattered foci of punctate granular staining
in cardiomyocytes.
Western Immunoblot
Analysis of medulla oblongata samples from CWD
WTD-
inoculated reindeer by western immunoblot demonstrated
proteinase K-resistant PrP (PrP
res) in the 2 clinically affected
animals (Figure 2) but not in the 3 animals inoculated with
CWD
ELK (data not shown). The PrP
res glycosylation patterns (di-
, mono- and unglycosylated bands) observed in the clinical
reindeer were comparable in molecular weight and glycoform
ratio to that of the original white-tailed deer inoculum.
PRNP Sequence Analysis
Sequencing of the prion protein coding region (PRNP) revealed
some variability among the 6 reindeer. The PRNP from reindeer
12 and 47 encoded a PrP amino acid sequence identical to that of
mule deer (Figure 3), and both reindeer were susceptible to
infection with CWD
WTD. In contrast, PRNP from reindeer 2 and
60 were heterozygous at bases 4 (codon 2, V/M), 385 (codon 129,
G/S), 413 (codon 138, S/N), and 505 (codon 169, V/M) of PRNP
(cervid numbering), and completely resisted infection with
CWD
ELK up to 60 mpi (Table 1). Finally, reindeer 1 and 17
were heterozygous at base 413 (codon 138, S/N) of PRNP.
Reindeer 1 was euthanized at 22.6 mpi with no evidence of
PrP
CWD in any tissue. Reindeer 17 is still alive and without clinical
signs at 26 mpi and thus far has no PrP
CWD in lymphoid tissue,
implicating 138 N as a protective polymorphism. All reindeer
were methionine homozygous at codon 132 of the cervid prion
protein, which corresponds to polymorphic codon 129 in humans.
Discussion
The current study demonstrates the oral transmission of CWD
from the brain tissues of infected white-tailed deer to reindeer
(Rangifer tarandus tarandus). Antemortem testing identified PrP
CWD
in two reindeer at 13.4 mpi and both animals manifested
consistent clinical symptoms and succumbed to disease by 20
months. The course of disease progression and widespread
distribution of PrP
CWD in nervous and lymphoreticular systems
are consistent with observations from other cervids naturally or
experimentally infected with CWD, including elk, white-tailed
deer, mule deer, moose and red deer [9,10,11]. A natural case of
CWD in reindeer or caribou has not yet been identified but given
the potential overlap in habitat with infected free-ranging cervid
populations and the current findings of oral transmissibility, the
potential for natural transmission certainly exists.
Cervids with terminal CWD typically display PrP
CWD deposi-
tion throughout multiple organ systems which progresses from
early lymphatic tissue involvement, to central and peripheral
nervous tissues followed by accumulation in other tissues including
the endocrine system and heart [12,13]. In our study, RAMALT
sampling prior to 13.4 mpi was not conducted precluding an
accurate determination of when lymphoid involvement occurred,
although PrP
CWD has been detected in peripheral lymphoid tissue
as early as 42 d after oral inoculation of mule deer fawns [14]. Our
observations of PrP
CWD-specific staining in sections of pancreas,
pituitary, adrenal medulla, lung, kidney, bladder and salivary
gland corroborate findings in other CWD-infected cervids
[9,12,13], with PrP
CWD primarily localized to lymphoid or neural
components of these tissues. The presence of PrP
CWD in reindeer
excreta such as saliva, urine and feces is anticipated based on
studies in deer [1,2] but was not investigated here. Skeletal muscle
from CWD-infected mule deer has been shown to contain
infectivity [15] and PrP
CWD was recently reported in muscle-
associated nerve fascicles of white-tailed deer [16]. We were
unable to detect PrP
CWD in myocytes or associated nerves by IHC
Table 1. Summary of results from reindeer orally inoculated with CWD from elk or white-tailed deer.
a
ID
CWD
Inoculum
Clinical
Disease
b
Survival Time
(mpi) PRNP Genotype
c IHC
d WB ELISA
e
2 129 138 169 RAMALT Obex Obex LN
1 Elk No 22.6 VV GG SN VV 2 (17.5) 222 2
2 Elk No 60.9 VM GS SN VM 2 (54.8) 222 2
60 Elk No 45.3 VM GS SN VM 2 (17.5) 222 2
12 WTD 18.2 20.0 VV GG SS VV + (13.4) +++ (2.65) + (1.18)
47 WTD 17.7 18.5 VV GG SS VV + (13.4) +++ (2.81) + (1.65)
17 WTD No NA
f VV GG SN VV 2 (25.0) NA NA NA NA
aELISA = enzyme-linked immunosorbent assay; IHC = immunohistochemistry; LN = lymph node; mpi = months post-inoculation; NA = data not available; RAMALT =
Recto-anal mucosa associated lymphoid tissue; WB = Western blot; WTD = White-tailed deer.
bTime (mpi) to first clinical signs of neurological disease if observed.
cDeduced amino acids at codons 2-129-138-169. V= Valine; M= Methionine; G= Glycine; S= Serine; N= Asparagine.
dIHC conducted on RAMALT or obex tissue using mAb F99. The time of last RAMALT sampling is listed in parentheses (mpi) for animals with a negative IHC result, while
the time of the first positive RAMALT biopsy is listed for the positive animals.
eConducted on obex or retropharyngeal lymph node and reported as positive (+) or negative (–) with optical density (OD) in parentheses from a commercially available
ELISA kit (negative OD cut-off =0.21).
fAnimal 17 remains alive at 26 mpi with no evidence of clinical signs or PrP
CWD in RAMALT biopsy.
doi:10.1371/journal.pone.0039055.t001
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[9,12,17,18]. Regardless, the widespread distribution of PrP
CWD
in infected reindeer tissues merits consideration while evaluating
the risks emanating from processing or consuming potentially
infected animals.
None of the reindeer inoculated with CWD
ELK developed
clinical disease or accumulated PrP
CWD in any of the tissues tested.
The apparent resistance of reindeer to infection by the CWD
ELK
inoculum may relate to subtle differences in the CWD strains
present within the pooled elk and white-tailed deer inocula,
however, we think this is unlikely. Differences between the two
inocula were not evident through glycosylation profile analysis of
PrP
res by western blot (data not shown). Further characterization
of these inocula in transgenic mice is ongoing. We also considered
that this may have been due to a low prion titre in the elk
inoculum, however, the same CWD inoculum pool has been used
in other studies and was highly infectious for red deer [9] and elk
[19]. Alternatively, resistance could be due to the PRNP genotype,
in which heterozygous codons occurred at positions 2 (V/M), 129
(G/S), 138 (S/N), and 169 (V/M) in the mature form of PrP
C.A n
important role for PRNP polymorphisms in determining disease
susceptibility is also suggested by the finding that one of the three
reindeer has not yet succumbed to infection with the CWD
WTD
inoculum by 26 mpi and showed no detectable PrP
CWD in
lymphoid tissue at 25 mpi. This possibly resistant reindeer differs
from the susceptible reindeer in being heterozygous at a single
codon 138 (S/N).
Table 2. PrP
CWD distribution in tissues of reindeer orally inoculated with brain tissue from CWD-infected white-tailed deer.
System, anatomical site
Detection of
PrP
CWDa System, anatomical site
Detection of
PrP
CWDa
Central nervous system Lymphoreticular system
Frontal cortex + RAMALT +
Basal ganglia + Nictitating membrane +
Thalamus + Palatine tonsil +
Midbrain + Retropharyngeal LN +
Rostral medulla + Parotid LN +
Obex + Submandibular LN +
Cerebellum + Pre-scapular LN +
Spinal cord (C5, T6, L5) + Mediastinal LN +
Peripheral nervous system Tracheobronchial LN +
Trigeminal ganglia + Hepatic LN +
Celiac ganglia + Rumenal LN +
Vagus nerve + Abomasal LN +
Phrenic nerve 2 Mesenteric LN +
Sympathetic trunk + Ileocecal LN +
Sciatic nerve 2 Sublumbar lN +
Gastrointestinal system Pre-femoral LN +
Submandibular salivary gland + Popliteal LN +
Parotid salivary gland 2 Spleen +
Esophagus + Musculoskeletal system
Rumen + Tongue 2
Reticulum + Masseter 2
Abomasum + Diaphragm 2
Omasum + Trapezius 2
Duodenum + Triceps brachii 2
Jejunum + Semitendinosus 2
Ileum + Psoas major 2
Ceacum + Other tissues
Colon + Heart +
Endocrine system Lung +
Pancreas + Nasal mucosa +
Adrenal gland + Liver 2
Thyroid gland + Kidney +
Pituitary gland + Bladder +
aPrP
CWD was detected by IHC with MAb F99/97.6.1 and a commercially available TSE ELISA kit and results are expressed as PrP
CWD present (+) or not detected (2).
RAMALT, recto-anal mucosa-associated lymphoid tissue; LN, lymph node.
doi:10.1371/journal.pone.0039055.t002
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unknown. Interestingly, 138 N is common to the 4 reindeer that
resisted elk or white-tailed deer CWD infection and may offer
some protection. Consistent with this possibility, fallow deer were
reported to express a PRNP gene encoding 138 N and 226 E and
resisted infection when housed together with CWD-infected mule
deer for 7 years [20]. Residue 138 N was implicated as the residue
possibly protective against CWD infection, since red deer that
express PrP
C with 226 EE are highly susceptible to elk CWD
infection [9]. Fallow deer were shown to be susceptible to CWD
inoculation by the intracerebral route with long incubation periods
of 4–5 years [21]. Nevertheless, it will be important to determine
whether fallow deer resist CWD after an oral challenge.
Codon 138 is in the b12a1 loop region [22]. Although serine
and asparagine are similar small, polar residues, serine/asparagine
differences at position 173 (elk numbering) of the b22a2 loop may
impact the susceptibility of a species to CWD infection [23,24].
Additionally, crystal structures of the b22a2 loop peptides have
shown that 173 (S/N) and 177 (N/T) sequence differences modify
how the side chains pack at the b-sheet interface, and suggest that
this incompatibility may underlie transmission barriers [25].
Whether serine or asparagine at position 138 has a similar effect
on b-sheet packing is not yet known.
Would the reindeer that were heterozygous at 2 (V/M), 129 (G/
S), 138 (S/N), and 169 (V/M) completely resist CWD infection or
require a long incubation period to develop PrP
CWD or clinical
signs of disease? No trace of PrP
CWD in lymphoid tissue or any
other tissues at the end of the experiment (60 mpi) suggests at
minimum a long delay in developing CWD infection, and at best
complete protection from CWD infection.
In North America, the term reindeer describes a domesticated
Rangifer tarandus subspecies (Rangifer tarandus tarandus) introduced
from Eurasia approximately a century ago, while the term caribou
refers to several native wild Rangifer tarandus subspecies. Major
caribou subspecies include woodland (Rangifer tarandus caribou) and
barren-ground (Rangifer tarandus groenlandicus, Rangifer tarandus granti)
caribou [26]. Barren-ground caribou generally exist in higher
northern latitudes, in some regions commingling with semi-
domesticated reindeer herds, while the range of woodland caribou
extends further south into the provinces of Alberta and Saskatch-
ewan which currently harbour CWD-infected cervids. A study of
95 caribou in northern Quebec failed to identify CWD [27],
although CWD has not yet been detected in Canadian provinces
east of Saskatchewan.
Interbreeding between reindeer and caribou has occurred in
captivity and the wild although general genetic introgression
appears to be minimal [28]. Two of the reindeer protected from
CWD were heterozygous at 4 codons that were in common with
the reported genotypes of Rangifer tarandus granti [29] and differ
from Rangifer tarandus tarandus (unpublished, Genbank accession
#AY639093.01). It is possible that the two resistant reindeer were
derived from interbreeding two Rangifer tarandus subspecies,
potentially captive and free-ranging. It will be crucial to determine
the prevalence of the polymorphisms in both free-ranging and
captive reindeer populations, particularly considering the possible
protective PRNP residues.
Large scale analysis of PRNP alleles in reindeer has not been
reported. Largely consistent with our findings in captive reindeer,
Happ et al. [29] recently sequenced PRNP from three free-ranging
caribou herds in Alaska and identified polymorphisms at codons 2
(V/M), 129 (G/S), 138 (S/N) and 169 (V/M). Moreover, the most
frequent caribou allele across the 3 herds examined was VGSV,
which is common to the 2 reindeer we found to be susceptible to
CWD
WTD. The close interrelatedness of Rangifer species implies
disease susceptibility in one may predict susceptibility in the
Figure 2. Western immunoblot of PrP
res in the brainstem of
reindeer compared to elk and white-tailed deer CWD inocula.
Reindeer 12 (lane 4) and reindeer 47 (lane 5) developed terminal CWD
at 18.5 and 20 mpi. Lane 1– molecular weight marker (kDa), lane 2–
CWD in elk, lane 3– CWD in white-tailed deer, lane 4– CWD in reindeer
12, lane 5– CWD in reindeer 47, lane 6– negative control elk.
doi:10.1371/journal.pone.0039055.g002
Figure 3. PRNP sequence of the reindeer used in this study compared with mule deer, white-tailed deer, Rocky Mountain elk, and
moose. Reindeer are polymorphic at codons 2 (M/V), 129 (S/G), 138 (S/N), and 169 (M/V). PRNP polymorphisms have also been reported in Rocky
Mountain elk (132 M/L), mule deer (20 D/G, 225 S/F), white-tailed deer (95 Q/H, 96 G/S, 116 A/G, 226 Q/R, and 230 Q/L) and moose 209 (M/I)
[11,41,44,45,46,47,48].
doi:10.1371/journal.pone.0039055.g003
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could confer resistance.
The importance of Rangifer species to the culture of aboriginal
peoples cannot be underestimated with many components of
hunted animals being consumed as food. Although relatively
limited in comparison to elk and deer industries in North
America, reindeer and caribou farming does occur, producing
consumables such as meat, hides and antler velvet. The human
health risks of consuming meat or other products derived from
CWD-infected animals remain uncertain, although epidemio-
logical evidence indicates transmission has not yet occurred
[30,31,32] and transgenic mouse studies suggest the risk is
remote in humans expressing common PRNP sequences
[33,34,35]. The finding that CWD can be transmitted to
squirrel monkeys by intracranial inoculation [36] raises concern
for human transmissibility, however a study in macaques failed
to demonstrate transmission after 70 months [37]. Since prion
strains may undergo changes in transmission characteristics
following passage through different species and strain selection
pressures can be exerted by host genetic factors during passage
within a species [24,38,39,40], caution is warranted when
predicting the risks of CWD transmission from reindeer to other
species.
This is the first evidence of CWD transmission to the sub-species
Rangifer tarandus tarandus, implicating the potential for transmission
to others in this genus. Current diagnostic tests, including
antemortem RAMALT testing, appear capable of detecting
CWD in Rangifer species and increased surveillance would be
required to determine if natural transmission has indeed occurred.
Additional studies are ongoing to chart the distribution of
infectivity during the course of disease and determine the influence
of PRNP polymorphisms in disease susceptibility.
Materials and Methods
Ethics Statement
All experimental procedures involving animals were performed
under strict accordance with Canadian Council on Animal Care
guidelines in such a manner as to minimize suffering. Protocols
were approved and monitored by the Animal Care Committee at
the Canadian Food Inspection Agency, Ottawa Laboratory –
Fallowfield.
Recipient Animals and Experimental Challenge
The transmissibility of Canadian elk (CWD
ELK) and white-
tailed deer (CWD
WTD) CWD inocula was investigated in two
groups of three, six-month-old reindeer sourced from CWD-free
captive herds. Animals were group housed in isolation barns at the
Canadian Food Inspection Agency, Ottawa Laboratory – Fallow-
field (Ottawa, Ontario).
Inocula were prepared as pooled brain homogenates containing
5 g of brain material in 20 ml of physiological saline. The
CWD
ELK inoculum contained material from 12 animals in one
captive herd while the CWD
WTD inoculum was derived from 3
positive animals in a different captive herd and mixing of animals
between herds had not knowingly occurred. All source animals
were clinically affected by CWD and were confirmed positive by
ELISA, western blot and IHC. Reindeer were orally inoculated
with two 5 g doses of either elk or white-tailed deer brain
homogenate on days 0 and 7 of the trial. Each dose was delivered
by syringe to the oropharynx and infected animals were monitored
daily for evidence of clinical disease.
Genotyping
Genotype analysis was conducted on nucleic acid extracted
from live animal blood samples using a purification kit following
the manufacturer’s protocols (Purelink, Invitrogen). Genomic
DNA was used as a template in PCR to amplify the PRNP open
reading frame using a high fidelity polymerase (Platinum Pfx
DNA Polymerase, Invitrogen) and the following primers: forward
59-GGGCATATGATGCTGACACCCTCTTT and reverse 59-
GAGAAAAATGAGGAAAGAGATGAGGAGG. Reaction con-
ditions were as follows: 94uC for 2 min followed by 35 cycles of
denaturation (94uC, 15 sec), annealing (53uC, 30 sec), and
extension (68uC, 48 sec). PCR amplicons were gel purified,
cloned into a Topo-TA cloning vector (Invitrogen), and
sequenced using the T7 primer to obtain sequences from at
least 10 clones with the PRNP gene. Genotyping of reindeer 1
was conducted on antler velvet using the previously described
method [41].
Ante-mortem and Post-mortem Tissue Collection
At several points during each study animals were sedated with a
mixture of ketamine and xylazine for blood collection and biopsy
of recto-anal mucosa associated lymphoid tissue (RAMALT).
RAMALT biopsies were obtained and evaluated by IHC as
previously described [9,42] and were subjected to testing by
commercially available TSE detection kits (TeSeE ELISA and
TeSeE Western blot, Bio-Rad Laboratories).
If animals displayed evidence of discomfort, immobility or
terminal CWD, or reached specific time points in the study they
were euthanized with sodium pentobarbital. A broad range of
neural and non-neural tissues from all major organ systems were
collected (Table 2) and adjacent tissue samples were frozen at
280uC or fixed in 10% neutral buffered formalin.
Immunohistochemical and PET Blot Testing
Formalin-fixed tissues were embedded into paraffin wax,
sectioned at 5-mm thickness and stained with hematoxylin and
eosin or by IHC as previously described [9]. Briefly, following
antigen retrieval by autoclaving in citrate buffer solution
(DAKO Target Antigen Retrieval), IHC for PrP
CWD was
performed on an automated immunostainer (Ventana Medical
Systems, Tucson, Arizona, USA) using the monoclonal antibody
F99/97.6.1 (VMRD, Pullman, Washington, USA) and AEC
detection kit (Ventana Medical Systems). Positive and negative
staining were differentiated based on comparisons with control
tissues included in each run. Paraffin-embedded tissue (PET)
blot was conducted as previously described [43], mounting
paraffin-embedded sections on a polyvinylidene fluoride (PVDF)
membrane (Immobilon-P, Millipore), digesting with Proteinase
K (250 mg/ml) and staining with F99/97.6.1 (VMRD, Pullman,
Washington, USA).
ELISA and Western Blot
Fresh or previously frozen unfixed tissue samples were analysed
by ELISA and western blot using commercially available TSE
detection kits (TeSeE ELISA and TeSeE Western blot, Bio-Rad
Laboratories) according to manufacturer’s instructions and as
previously described [9]. The ELISA cutoff value was calculated as
the average optical density readings of the negative controls plus a
fixed value of 0.09 units. Western blots were run with molecular
mass markers and CWD positive and negative control elk brain
homogenates.
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